Evaxion Biotech AS
Biotechnology
Healthcare
EVAX
316 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
3.06
52 week high
6.03
high
3.15
52 week low
0.00
low
3.02
growth
1.00 %
previous Close
3.05
P/E ratio
-3
market cap
20.53 M
div yield
0
usd
Jun 2025
qoq
revenue
37.00 K
-69.67 %
net incoming
-4.83 M
-33.12 %
eps
-1.00 %
68.19 %
eps surprise
-72.41 %
net profit margin
-13056.76 %
-10082.00 %
operating incoming
-4.34 M
-7.85 %
net change in cash
0.00 %
cash on hand
14.75 M
191.88 %
cost of revenue
0.00 %
top top